Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Taxes (2022 - 2025)

Sunshine Biopharma's Current Taxes history spans 4 years, with the latest figure at $268276.0 for Q4 2025.

  • For Q4 2025, Current Taxes changed 0.0% year-over-year to $268276.0; the TTM value through Dec 2025 reached $268276.0, changed 0.0%, while the annual FY2025 figure was $268276.0, 0.0% changed from the prior year.
  • Current Taxes reached $268276.0 in Q4 2025 per SBFM's latest filing, up from $258158.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $416245.0 in Q1 2023 to a low of $201541.0 in Q3 2023.
  • Average Current Taxes over 4 years is $275763.8, with a median of $256564.5 recorded in 2024.
  • The largest YoY upside for Current Taxes was 26.51% in 2024 against a maximum downside of 38.74% in 2024.
  • A 4-year view of Current Taxes shows it stood at $373191.0 in 2022, then fell by 19.65% to $299869.0 in 2023, then decreased by 10.54% to $268276.0 in 2024, then changed by 0.0% to $268276.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Current Taxes are $268276.0 (Q4 2025), $258158.0 (Q2 2025), and $228115.0 (Q1 2025).